Where are the new analgesics? An alternative approach to early phase analgesic trials using a multivariable input model with adaptively allocated enrichment

Pain

Volumn 151, Issue 2, 2010, Pages 247-250

  Quessy, Steve N ^a  

^a qd Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ANALGESIC ACTIVITY; EVALUATION; HUMAN; INPUT VARIABLE MODEL; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; POPULATION MODEL; PRIORITY JOURNAL; REVIEW; STUDY DESIGN; VALIDITY;

ANALGESICS; ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MODELS, BIOLOGICAL; PAIN;

EID: 77957906763     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.05.025     Document Type: Review

References (40)

1. C.E. Argoff, B.S. Galer, M.P. Jensen, N. Oleka, and A.R. Gammaitoni Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale Curr Med Res Opin 20 2004 S21 S28
2. R.L. Barbano, D.N. Herrmann, S. Hart-Gouleau, J. Pennella-Vaughan, P.A. Lodewick, and R.H. Dworkin Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy Arch Neurol 61 2004 914 918
3. R. Baron, V. Mayoral, G. Leijon, A. Binder, I. Steigerwald, and M. Serpell 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study Curr Med Res Opin 25 2009 1663 1676
4. B.A. Chizh, M.B. O'Donnell, A. Napolitano, J. Wang, A.C. Brooke, M.C. Aylott, J.N. Bullman, E.J. Gray, R.Y. Lai, P.M. Williams, and J.M. Appleby The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans Pain 132 2007 132 141
5. B.A. Chizh, T. Priestley, M. Rowbotham, and K. Schaffler Predicting therapeutic efficacy - experimental pain in human subjects Brain Res Rev 60 2009 243 254
6. T.B. Dougherty, V.H. Porche, and P.F. Thall Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesia Anesthesiology 92 2000 1010 1016
7. V. Dragalin Adaptive designs: terminology and classification Drug Inf J 40 2006 425 435
8. A.R. Frymoyer, M.C. Rowbotham, and K.L. Petersen Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers J Pain 8 2007 19 25
9. B.S. Galer, D. Lee, T. Ma, B. Nagle, and T.G. Schlagheck MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance Pain 115 2005 284 295
10. P. Gallo, C. Chuang-Stein, V. Dragalin, B. Gaydos, M. Krams, and J. Pinheiro Adaptive designs in clinical drug development - an executive summary of the PhRMA Working Group J Biopharm Stat 16 2006 275 283
11. B. Gaydos, M. Krams, I. Perevozskaya, F. Bretz, Q. Liu, P. Gallo, D. Berry, C. Chuang-Stein, J. Pinheiro, and A. Bedding Adaptive dose-response studies Drug Inf J 40 2006 451 461
12. I. Gilron, S.L. Booher, M.S. Rowan, M.S. Smoller, and M.B. Max A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias Neurology 55 2000 964 971
13. J. Gimbel, R. Linn, M. Hale, and B. Nicholson Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study Am J Ther 12 2005 311 319
14. H. Gottrup, G. Juhl, A.D. Kristensen, R. Lai, B.A. Chizh, J. Brown, F.W. Bach, and T.S. Jensen Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia Anesthesiology 101 2004 1400 1408
15. D.B. Hall, U. Meier, and H.C. Diener A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials Contemp Clin Trials 26 2005 349 364
16. D.N. Herrmann, R.L. Barbano, S. Hart-Gouleau, J. Pennella-Vaughan, and R.H. Dworkin An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy Pain Med 6 2005 379 384
17. J. Katz, N.B. Finnerup, and R.H. Dworkin Clinical trial outcome in neuropathic pain: relationship to study characteristics Neurology 70 2008 263 272
18. B. Kraft, N.A. Frickey, R.M. Kaufmann, M. Reif, R. Frey, B. Gustorff, and H.G. Kress Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers Anesthesiology 109 2008 101 110
19. J. Kuhlmann Alternative strategies in drug development: clinical pharmacological aspects Int J Clin Pharmacol Ther 37 1999 575 583
20. R.L. Lalonde, K.G. Kowalski, M.M. Hutmacher, W. Ewy, D.J. Nichols, P.A. Milligan, B.W. Corrigan, P.A. Lockwood, S.A. Marshall, L.J. Benincosa, T.G. Tensfeldt, K. Parivar, M. Amantea, P. Glue, H. Koide, and R. Miller Model-based drug development Clin Pharmacol Ther 82 2007 21 32
21. H.J. Lemmens, D.R. Wada, C. Munera, A. Eltahtawy, and D.R. Stanski Enriched analgesic efficacy studies: an assessment by clinical trial simulation Contemp Clin Trials 27 2006 165 173
22. M.E. Lynch, A.J. Clark, and J. Sawynok Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design Pain 103 2003 111 117
23. A. Maloney, M.O. Karlsson, and U.S. Simonsson Optimal adaptive design in clinical drug development: a simulation example J Clin Pharmacol 47 2007 1231 1243
24. J. Mao Translational pain research: achievements and challenges J Pain 10 2009 1001 1011
25. H.J. McQuay, S. Derry, R.A. Moore, P. Poulain, and V. Legout Enriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic pain Pain 135 2008 217 220
26. K.L. Petersen, B. Jones, V. Segredo, J.B. Dahl, and M.C. Rowbotham Effect of remifentanil on pain and secondary hyperalgesia associated with the heat-capsaicin sensitization model in healthy volunteers Anesthesiology 94 2001 15 20
27. S.N. Quessy Comment on: animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and a call for uniform reporting standards Pain 142 2009 284 285
28. S.N. Quessy Two-stage enriched enrolment pain trials: a brief review of designs and opportunities for broader application Pain 148 2010 8 13
29. S.N. Quessy, and M.C. Rowbotham Placebo response in neuropathic pain trials Pain 138 2008 479 483
30. S.N. Raja, and J.A. Haythornthwaite Combination therapy for neuropathic pain - which drugs, which combination, which patients? N Engl J Med 352 2005 1373 1375
31. J. Raskin, Y.L. Pritchett, F. Wang, D.N. D'Souza, A.L. Waninger, S. Iyengar, and J.F. Wernicke A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain Pain Med 6 2005 346 356
32. R. Rolke, R. Baron, C. Maier, T.R. Tolle, R.D. Treede, A. Beyer, A. Binder, N. Birbaumer, F. Birklein, I.C. Botefur, S. Braune, H. Flor, V. Huge, R. Klug, G.B. Landwehrmeyer, W. Magerl, C. Maihofner, C. Rolko, C. Schaub, A. Scherens, T. Sprenger, M. Valet, and B. Wasserka Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values Pain 123 2006 231 243
33. C.N. Sang, S. Booher, I. Gilron, S. Parada, and M.B. Max Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials Anesthesiology 96 2002 1053 1061
34. T.J. Schnitzer, M. Kamin, and W.H. Olson Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study Arthritis Rheum 42 1999 1370 1377
35. D.M. Simpson, J.C. McArthur, R. Olney, D. Clifford, Y. So, D. Ross, B.J. Baird, P. Barrett, and A.E. Hammer Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial Neurology 60 2003 1508 1514
36. M.K. Smith, I. Jones, M.F. Morris, A.P. Grieve, and K. Tan Implementation of a Bayesian adaptive design in a proof of concept study Pharm Stat 5 2006 39 50
37. M.K. Smith, and S. Marshall A Bayesian design and analysis for dose-response using informative prior information J Biopharm Stat 16 2006 695 709
38. R. Staud, and D.D. Price Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors Pain 136 2008 232 234
39. U. Thienel, W. Neto, S.K. Schwabe, and U. Vijapurkar Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials Acta Neurol Scand 110 2004 221 231
40. J.F. Wernicke, Y.L. Pritchett, D.N. D'Souza, A. Waninger, P. Tran, S. Iyengar, and J. Raskin A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain Neurology 67 2006 1411 1420 (Pubitemid 44632065)